Roivant Sciences (ROIV) Update / Briefing June 17, 2025 01:00 PM ET Speaker0 Good morning, and thanks for joining today's brepicitinib investor call. We expect this call to run for approximately sixty to seventy five minutes with prepared remarks around forty to forty five minutes and the remainder spent on q and a. Presenting today, we have Mac Line, CEO of Regan, and Ben Zimmer, CEO of Privyant. You can find the slides being presented today on our IR website at www.investor.regan.com. I would like to remi ...